Loading...
Cigna Corporation
CI•NYSE
HealthcareMedical - Healthcare Plans
$312.17
$1.15(0.37%)
Cigna Corporation (CI) Financial Performance & Statements
Review Cigna Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
25.21%
↑ 25.21%
Operating Income Growth
-38.27%
↓ 38.27%
Net Income Growth
-33.50%
↓ 33.50%
Operating Cash Flow Growth
-12.27%
↓ 12.27%
Operating Margin
2.69%
↑ 2.69%
Gross Margin
100.00%
↑ 100.00%
Net Profit Margin
1.98%
↑ 1.98%
ROE
12.23%
↑ 12.23%
ROIC
7.20%
↑ 7.20%
Cigna Corporation (CI) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Cigna Corporation stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $65.72B | $62.77B | $60.48B | $55.42B |
| Cost of Revenue | $59.26B | $0.00 | $0.00 | $0.00 |
| Gross Profit | $6.46B | $62.77B | $60.48B | $55.42B |
| Gross Profit Ratio | $0.10 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.87B | $3.59B | $3.68B | $3.71B |
| Operating Expenses | $63.71B | $61.58B | $58.49B | $55.34B |
| Total Costs & Expenses | $63.48B | $61.58B | $58.49B | $55.34B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $362.00M | $376.00M | $375.00M | $322.00M |
| Depreciation & Amortization | $646.00M | $650.00M | $738.00M | $741.00M |
| EBITDA | $2.94B | $2.22B | $3.10B | $1.14B |
| EBITDA Ratio | $0.04 | $0.04 | $0.05 | $0.02 |
| Operating Income | $2.009B | $1.19B | $1.99B | $79.00M |
| Operating Income Ratio | $0.03 | $0.02 | $0.03 | $0.001 |
| Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Before Tax | $2.009B | $1.19B | $1.99B | $79.00M |
| Income Before Tax Ratio | $0.03 | $0.02 | $0.03 | $0.001 |
| Income Tax Expense | $473.00M | $367.00M | $360.00M | $291.00M |
| Net Income | $1.42B | $739.00M | $1.55B | -$277.00M |
| Net Income Ratio | $0.02 | $0.01 | $0.03 | -$0.005 |
| EPS | $5.13 | $2.65 | $5.51 | -$0.97 |
| Diluted EPS | $5.13 | $2.63 | $5.45 | -$0.97 |
| Weighted Avg Shares Outstanding | $277.97M | $281.40M | $281.13M | $286.46M |
| Weighted Avg Shares Outstanding (Diluted) | $277.78M | $281.40M | $284.05M | $286.46M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan